KNTE - Kinnate Biopharma Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - KNTE (1797768)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-05-08
KNTETananbaum James B.Dir, 10%P - Purchase$2.80+1,780,00010,192,354+21%+$4,984,000
2023-05-08
KNTEForesite Capital Management Iv, LLC10%P - Purchase$2.80+1,780,00010,192,354+21%+$4,984,000
M
2023-05-04
KNTEOrbimed Advisors LLCDir, 10%P - Purchase$2.80+1,460,9321,902,937+331%+$4,086,235
M
2023-05-04
KNTEGordon Carl LDir, 10%P - Purchase$2.80+1,460,9321,902,937+331%+$4,086,235
M
2023-04-28
KNTEGordon Carl LDir, 10%P - Purchase$2.61+1,405,1681,328,967-1844%+$3,673,901
M
2023-04-28
KNTEOrbimed Advisors LLCDir, 10%P - Purchase$2.61+1,405,1681,328,967-1844%+$3,673,901

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top